✦ LIBER ✦

Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancer

✍ Scribed by Harris, Adrian L.; Cantwell, Brian M.J.; Carmichael, James; Dawes, Peter; Robinson, Angie; Farndon, John; Wilson, Ron

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trilostane plus hydrocortisone in postme

✍ T'Hooft-Andry, M.; Focan, C.; Clarysse, A.; Michel, J.; Heuson, J.C.; Paridaens, 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 153 KB

Second line endocrine treatment of postm

✍ Bruning, P.F.; Bonfrèr, J.M.G.; Wildiers, J.; Jassem, J.; Beex, L.V.A.M.; Schorn 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 514 KB

Results of a phase II study comparing th

✍ Kathleen I. Pritchard; Janusz Rolski; Zsuzsanna Papai; Louis Mauriac; Fatima Car 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 363 KB

A Multicenter, Single-Arm Phase II Study

✍ Miguel Martin; Maria Blasinska-Morawiec; J. Fernando Salas; Silvia Falcon; Janus 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 119 KB

Preliminary results of a Phase II study

✍ M. Hayashi; Oyama; M. Sunagawa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Daily low-dose cisplatin plus concurrent

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 150 KB